Beyer M - Search Results

1

Zanolimumab, a human monoclonal antibody targeting CD4 in the treatment of mycosis fungoides and Sézary syndrome.

Mestel DS, Beyer M, Möbs M, Steinhoff M, Sterry W, Assaf C. Mestel DS, et al. Among authors: beyer m. Expert Opin Biol Ther. 2008 Dec;8(12):1929-39. doi: 10.1517/14712590802528696. Expert Opin Biol Ther. 2008. PMID: 18990079 Review.

2

The treatment of mycosis fungoides.

Mestel DS, Beyer M, Steinhoff M, Sterry W, Assaf C. Mestel DS, et al. Among authors: beyer m. G Ital Dermatol Venereol. 2008 Dec;143(6):395-408. G Ital Dermatol Venereol. 2008. PMID: 19169212 Review.

3

Treatment of cutaneous lymphomas: today and tomorrow.

Mestel DS, Beyer M, Steinhoff M, Sterry W. Mestel DS, et al. Among authors: beyer m. Actas Dermosifiliogr. 2009 Nov;100 Suppl 1:18-32. doi: 10.1016/s0001-7310(09)73165-5. Actas Dermosifiliogr. 2009. PMID: 20096194

4

Emerging drugs in cutaneous T cell lymphoma.

Mestel DS, Assaf C, Steinhoff M, Beyer M, Moebs M, Sterry W. Mestel DS, et al. Among authors: beyer m. Expert Opin Emerg Drugs. 2008 Jun;13(2):345-61. doi: 10.1517/14728214.13.2.345. Expert Opin Emerg Drugs. 2008. PMID: 18537525 Review.

5

Pathogenesis of Mycosis fungoides.

Beyer M, Möbs M, Humme D, Sterry W. Beyer M, et al. J Dtsch Dermatol Ges. 2011 Aug;9(8):594-8. doi: 10.1111/j.1610-0387.2011.07635.x. Epub 2011 Mar 3. J Dtsch Dermatol Ges. 2011. PMID: 21371258 Review. English, German.

6

Analysis of the IL-31 pathway in Mycosis fungoides and Sézary syndrome.

Möbs M, Gryzik S, Haidar A, Humme D, Beyer M, Vandersee S. Möbs M, et al. Among authors: beyer m. Arch Dermatol Res. 2015 Aug;307(6):479-85. doi: 10.1007/s00403-014-1527-x. Epub 2014 Dec 7. Arch Dermatol Res. 2015. PMID: 25488078

7

Evaluation of different methods in the follow-up of patients with indolent types of primary cutaneous lymphomas.

Terhorst D, Mestel DS, Humme D, Sterry W, Beyer M. Terhorst D, et al. Among authors: beyer m. Br J Dermatol. 2012 Jun;166(6):1295-300. doi: 10.1111/j.1365-2133.2012.10896.x. Br J Dermatol. 2012. PMID: 22356095

8

Complete clinical remission of tumor-stage mycosis fungoides after acute extensive skin necroses, granulomatous reaction, and fever under treatment with bexarotene, vorinostat, and high-dose fenofibrate.

Steinhoff M, Beyer M, Roewert-Huber J, Lukowsky A, Assaf C, Sterry W. Steinhoff M, et al. Among authors: beyer m. J Am Acad Dermatol. 2008 May;58(5 Suppl 1):S88-91. doi: 10.1016/j.jaad.2007.07.012. J Am Acad Dermatol. 2008. PMID: 18489056

9

Yttrium-90 ibritumomab tiuxetan radioimmunotherapy in primary cutaneous B-cell lymphomas: first results of a prospective, monocentre study.

Maza S, Gellrich S, Assaf C, Beyer M, Spilker L, Orawa H, Munz DL, Sterry W, Steinhoff M. Maza S, et al. Among authors: beyer m. Leuk Lymphoma. 2008 Sep;49(9):1702-9. doi: 10.1080/10428190802258923. Leuk Lymphoma. 2008. PMID: 18661405 Clinical Trial.

10

Prevalence of genetically defined tumor cells in CD7 as well as CD26 positive and negative circulating T-cell subsets in Sézary syndrome.

Steinhoff M, Schöpp S, Assaf C, Muche M, Beyer M, Sterry W, Lukowsky A. Steinhoff M, et al. Among authors: beyer m. Leuk Res. 2009 Jan;33(1):88-99. doi: 10.1016/j.leukres.2008.06.025. Epub 2008 Jul 30. Leuk Res. 2009. PMID: 18672285

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

819 results

Search Page